As we get older, the risk of hospitalisation from COVID-19 grows exponentially

Publicly released:
International
Corona_virus_Covid-19_FC By HFCM Communicatie - Own work, CC BY-SA 4.0
Corona_virus_Covid-19_FC By HFCM Communicatie - Own work, CC BY-SA 4.0

The risk of hospitalisation from COVID-19 doubles for every 16 years of age or, equivalently, increases by 4.5 per cent per year of life, an exponential growth in risk as we age, according to UK researchers. They say this mirrors the decline in the body's production of a type of immune cell called T-cells, which halves every 16 years. However, the researchers also found there was no evidence for differences in susceptibility to infection or infectiousness with age.

News release

From: The Royal Society

COVID-19 hospitalisation rates rise exponentially with age, inversely proportional to thymic T-cell production

COVID-19 hospitalisation rates follow an exponential relationship with age, doubling for every 16 years of age or equivalently increasing by 4.5% per year of life. This mirrors the well studied exponential decline of T-cell production, which halves every 16 years. COVID-19 can therefore be added to the list of other diseases with this property, including those caused by MRSA, MERS-CoV, West Nile virus, Streptococcus Pneumonia and certain cancers. Risk is also higher in men, consistent with the degree to which thymic involution (and the decrease in T-cell production with age) is more severe in men compared to women. 

Exponential COVID risk - The risk of COVID-19 hospitalisation increases exponentially with age, equivalent to a 4.5% increase per year of life. UK researchers found the rise mirrors an exponential reduction in the immune system’s T-cell production. There was no evidence for differences in susceptibility to infection or infectiousness with age.

 

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research The Royal Society, Web page The URL will go live at some point after the embargo ends
Journal/
conference:
Journal of the Royal Society Interface
Research:Paper
Organisation/s: University of Oxford, UK
Funder: Financial support from Wellcome Trust (grant no. ID 211944/Z/18/Z).
Media Contact/s
Contact details are only visible to registered journalists.